Thirty-nine Shiga toxin–producing Escherichia coli (STEC) O113 Irish farm, abattoir, and clinical isolates were analyzed in conjunction with eight Australian, New Zealand, and Norwegian strains for H (flagellar) antigens, virulence gene profile (eaeA, hlyA, tir, espA, espB katP, espP, etpD, saa, sab, toxB, iha, lpfAO157/OI-141,lpfAO113, and lpfAO157/OI-154), Shiga toxin gene variants (stx1c, stx1d, stx2, stx2c, stx2dact, stx2e, stx2f, and stx2g) and were genotyped using pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). All of the Irish strains were O113:H4, regardless of source, while all non-Irish isolates carried the H21 flagellar antigen. The stx1 gene was present in 30 O113:H4 strains only, whereas the stx2d gene was common to all isolates regardless of source. In contrast, eaeA was absent, while hlyA was found in the Australian, New Zealand, Norwegian, and two of the Irish human clinical isolates. saa was present in the O113:H21 but not in the O113:H4 serotype. To the best of the author's knowledge, this is the first report of clinically significant STEC lacking both the eaeA and saa genes. PFGE analysis was inconclusive; however, MLST grouped the strains into three sequence types (ST): ST10, ST56, and ST223. Based on our findings, it was concluded that the stx2d gene is common in STEC O113, which are generally eaeA negative. Furthermore, STEC O113:H4 is a new, emerging bovine serotype of human clinical significance.
Anonymous. The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents and Food-Borne Outbreaks in the European Union in 2009. EFSA J, 2011; 9:2090.
3.
BeutinL, ZimmermannS, GleierK. Human infections with Shiga toxin–producing Escherichia coli other than serogroup O157 in Germany. Emerg Infect Dis, 1998; 4:635–639.
4.
BeutinL, KaulfussS, CheastyT, BrandenburgB, ZimmermannS, GleierK, WillshawGA, SmithHR. Characteristics and association with disease of two major subclones of Shiga toxin (Verocytotoxin)–producing strains of Escherichia coli (STEC) O157 that are present among isolates from patients in Germany. Diagn Microbiol Infect Dis, 2002; 44:337–346.
5.
BeutinL, KongQ, FengL, WangQ, KrauseG, LeomilL, JinQ, WangL. Development of PCR assays targeting the genes involved in synthesis and assembly of the new Escherichia coli O174 and O177 O antigens. J Clin Microbiol, 2005; 43:5143–5149.
6.
BlancoJ, BlancoM, BlancoJE, MoraA, GonzálezEA, BernárdezMI, AlonsoMP, CoiraA, RodriguezA, ReyJ, AlonsoJM, UseraMA. Verotoxin-producing Escherichia coli in Spain: Prevalence, serotypes, and virulence genes of O157:H7 and non-O157 VTEC in ruminants, raw beef products, and humans. Exp Biol Med (Maywood), 2003; 228:345–351.
7.
BlancoM, BlancoJE, DahbiG, MoraA, AlonsoMP, VarelaG, GadeaMP, SchelottoF, GonzálezEA, BlancoJ. Typing of intimin (eae) genes from enteropathogenic Escherichia coli (EPEC) isolated from children with diarrhea in Montevideo, Uruguay: Identification of two novel intimin variants (μB and ξR/β2B)J Med Microbiol, 2006; 55:1165–1174.
8.
BoltonDJ. Verocytotoxigenic (Shiga toxin–producing) Escherichia coli: Virulence factors and pathogenicity in the farm to fork paradigm. Foodborne Pathog Dis, 2011; 8:357–365.
9.
BosilevacJM, KoohmaraieM. Prevalence and characterization of non-O157 Shiga toxin–producing Escherichia coli isolated from commercial ground beef in the United States. Appl Environ Microbiol, 2011; 77:2103–2112.
10.
BrunderW, SchmidtH, KarchH. KatP, a novel catalase peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology, 1996; 142:3305–3315.
11.
BrunderW, SchmidtH, KarchH. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol Microbiol, 1997; 24:767–778.
12.
BürkC, DietrichR, AçarG, MoravekM, BülteM, MärtlbauerE. Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J Clin Microbiol, 2003; 41:2106–2112.
13.
CebulaTA, PayneWL, FengP. Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J Clin Microbiol, 1995; 33:248–250.
14.
DecludtB, BouvetP, Mariani-KurkdjianP, GrimontF, GrimontPA, HubertB, LoiratC. Haemolytic uraemic syndrome and Shiga toxin–producing Escherichia coli infection in children in France. The Société de Néphrologie Pédiatrique. Epidemiol Infect, 2000; 124:215–220.
15.
dos SantosLF, IrinoK, VazTM, GuthBE. Set of virulence genes and genetic relatedness of O113:H21 Escherichia coli strains isolated from the animal reservoir and human infections in Brazil. J Med Microbiol, 2010; 59:634–640.
16.
DoughtyS, SloanJ, Bennett-WoodV, RobertsonM, Robins-BrowneRM, HartlandEL. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement–negative strains of enterohemorrhagic Escherichia coli. Infect Immun, 2002; 70:6761–6769.
17.
FernándezD, IrinoK, SanzME, PadolaNL, ParmaAE. Characterization of Shiga toxin–producing Escherichia coli isolated from dairy cows in Argentina. Lett Appl Microbiol, 2010; 51:377–382.
18.
FrankeS, GunzerF, WielerLH, BaljerG, KarchH. Construction of recombinant Shiga-like toxin-IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status of pigs. Vet Microbiol, 1995; 43:41–52.
19.
FriedrichAW, BorellJ, BielaszewskaM, FruthA, TschäpeH, KarchH. Shiga toxin 1c–producing Escherichia coli strains: Phenotypic and genetic characterization and association with human disease. J Clin Microbiol, 2003; 41:2448–2453.
GarveyP, McKeownP, CarrollA, McNamaraE. Epidemiology of verotoxigenic E. coli in Ireland, 2006. Epi-Insight, 2008; 9:2–3.
22.
GarveyP, McKeownP, CarrollA, McNamaraE. Epidemiology of verotoxigenic E. coli in Ireland, 2007. Epi-Insight, 2009a. 10,9.
23.
GarveyP, McKeownP, CarrollA, McNamaraE. Epidemiology of verotoxigenic E. coli In Ireland, 2008. Epi-Insight, 2009b. 10,9.
24.
GriffinPM, TauxeRV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev, 1991; 13:60–98.
25.
GunzerF, BöhmH, RüssmannH, BitzanM, AleksicS, KarchH. Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic uremic syndrome. J Clin Microbiol, 1992; 30:1807–1810.
26.
HeroldS, PatonJC, PatonAW. Sab, a novel autotransporter of locus of enterocyte effacement–negative Shiga-toxigenic Escherichia coli O113:H21, contributes to adherence and biofilm formation. Infect Immun, 2009; 489:3234–3243.
27.
HiiJH, GylesC, MorookaT, KarmaliMA, ClarkeR, De GrandisS, BruntonJL. Development of verotoxin 2– and verotoxin 2 variant (VT2v)–specific oligonucleotide probes on the basis of the nucleotide sequence of the B cistron of VT2v from Escherichia coli E32511 and B2F1. J Clin Microbiol, 1991; 29:2704–2709.
28.
HoganMC, GloorJM, UhlJR, CockerillFR, MillinerDS. Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. Am J Kidney Dis, 2001; 38:1–6.
29.
JarvisKG, KaperJB. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect Immun, 1996; 64:4826–4829.
JerseAE, YuJ, TallBD, KaperJB. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA, 1990; 87:7839–7843.
32.
KarmaliMA, PetricM, LimC, FlemingPC, ArbusGS, LiorH. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis, 1985; 151:775–782.
KobayashiH, ShimadaJ, NakazawaM, MorozumiT, PohjanvirtaT, PelkonenS, YamamotoK. Prevalence and characteristics of Shiga toxin–producing Escherichia coli from healthy cattle in Japan. Appl Environ Microbiol, 2001; 67:484–489.
35.
KucziusT, BielaszewskaM, FriedrichAW, ZhangW. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol Nutr Food Res, 2004; 48:515–521.
36.
LakeR, HudsonA, CresseyP. Risk profile Shiga toxin–producing Escherichia coil in red meat and meat products. New Zealand Food Safety Authority, 2002. www.nzfsa.govt.nz/science/risk-profiles/stec-in-red-meat.pdf. 2012 October 1.
37.
LeungPH, PeirisJS, NgWW, Robins-BrowneRM, BettelheimKA, YamWC. A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. Appl Environ Microbiol, 2003; 69:7549–7553.
38.
LéveilléS, CazaM, JohnsonJR, ClabotsC, SabriM, DozoisCM. Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect Immun, 2006; 74:3427–3436.
39.
LucchesiPMA, KrugerA, ParmaAE. Distribution of saa gene variants in verocytotoxigenic Escherichia coli isolated from cattle and food. Res Microbiol, 2006; 157:263–266.
40.
McNallyA, RoeAJ, SimpsonS, Thomson-CarterFM, HoeyDE, CurrieC, ChakrabortyT, SmithDG, GallyDL. Differences in levels of secreted locus of enterocyte effacement proteins between human disease-associated and bovine Escherichia coli O157. Infect Immun, 2001; 69:5107–5114.[Retraction in: McNally A, et al. Infect Immun 2005; 73:2571.
41.
MellesDC, van LeeuwenWB, SnijdersSV, Horst-KreftD, PeetersJK, VerbrughHA, van BelkumA. Comparison of multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP) for genetic typing of Staphylococcus aureus. J Microbiol Methods, 2007; 69:371–375.
42.
Melton-CelsaAR, DarnellSC, O'BrienAD. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun, 1996; 64:1569–1576.
43.
MikoA, PriesK, HabyS, SteegeK, AlbrechtN, KrauseG, BeutinL. Assessment of Shiga toxin–producing Escherichia coli isolates from wildlife meat as potential pathogens for humans. Appl Environ Microbiol, 2009; 75:6462–6470.
44.
MonaghanA, ByrneB, FanningS, SweeneyT, McDowellD, BoltonDJ. Serotypes and virulence profiles of non-O157 Shiga toxin–producing Escherichia coli (STEC) from bovine farms. Appl Environ Microbiol, 2011; 77:8662–8668.
45.
MonaghanA, ByrneB, FanningS, SweeneyT, McDowellD, BoltonDJ. Serotypes and virulotypes of non-O157 Shiga toxin–producing Escherichia coli (STEC) on bovine hides and carcasses. Food Microbiol, 2012; 32:223–229.
46.
MuniesaM, RecktenwaldJ, BielaszewskaM, KarchH, SchmidtH. Characterization of a Shiga toxin 2e–converting bacteriophage from an Escherichia coli strain of human origin. Infect Immun, 2000; 68:4850–4855.
47.
PatonAW, PatonJC. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stx1, stx2, eaeA, enterohemorrhagic E. coli hlyA, rfbO111, and rfbO157. J Clin Microbiol, 1998; 36:598–602.
48.
PatonAW, PatonJC. Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113. Infect Immun, 1999; 67:5930–5937.
49.
PatonAW, PatonJC. Direct detection and characterization of Shiga toxigenic Escherichia coli by multiplex PCR for stx1, stx2, eae, ehxA, and saa. J Clin Microbiol, 2002; 40:271–274.
50.
PatonAW, RatcliffRM, DoyleRM, Seymour-MurrayJ, DavosD, LanserJA, PatonJC. Molecular microbiological investigation of an outbreak of hemolytic uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin–producing Escherichia coli. J Clin Microbiol, 1996; 34:1622–1627.
51.
PatonAW, WoodrowMC, DoyleRM, LanserJA, PatonJC. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic uremic syndrome. J Clin Microbiol, 1999; 37:3357–3361.
52.
PiérardD, StevensD, MoriauL, LiorH, LauwersS. Isolation and virulence factors of verocytotoxin-producing Escherichia coli in human stool samples. Clin Microbiol Infect, 1997; 3:531–540.
53.
PiérardD, MuyldermansG, MoriauL, StevensD, LauwersS. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol, 1998; 36:3317–3322.
54.
PragerR, AnnemullerS, TschapeH. Diversity of virulence patterns among Shiga toxin–producing Escherichia coli from human clinical cases—Need for more detailed diagnostics. Int J Med Microbiol, 2005; 295:29–38.
55.
RamachandranV, BrettK, HornitzkyMA, DowtonM, BettelheimKA, WalkerMJ, DjordjevicSP. Distribution of intimin subtypes among Escherichia coli isolates from ruminant and human sources. J Clin Microbiol, 2003; 41:5022–5032.
56.
RibotEM, FairMA, GautomR, CameronDN, HunterSB, SwaminathanB, BarrettTJ. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis, 2006; 3:59–67.
57.
RivasM, MiliwebskyE, ChinenI, RoldánCD, BalbiL, GarcíaB, FiorilliG, Sosa-EstaniS, KincaidJ, RangelJ, GriffinPM. Case-Control Study Group. Characterization and epidemiologic subtyping of Shiga toxin–producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis, 2006; 3:88–96.
58.
SchmidtH, RüssmannH, SchwarzkopfA, AleksicS, HeesemannJ, KarchH. Prevalence of attaching and effacing Escherichia coli in stool samples from patients and controls. Zentralbl Bakteriol, 1994; 281:201–213.
59.
SchmidtH, BeutinL, KarchH. Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect Immun, 1995; 63:1055–1061.
60.
SchmidtH, HenkelB, KarchH. A gene cluster closely related to type II secretion pathway operons of Gram-negative bacteria is located on the large plasmid of enterohemorrhagic in Escherichia coli O157 strains. FEMS Microbiol Lett, 1997; 148:265–272.
61.
SchmidtH, ScheefJ, MorabitoS, CaprioliA, WielerLH, KarchH. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol, 2000; 66:1205–1208.
62.
SchmidtH, ZhangWL, HemmrichU, JelacicS, BrunderW, TarrPI, DobrindtU, HackerJ, KarchH. Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement–negative, Shiga toxin–producing Escherichia coli. Infect Immun, 2001; 69:6863–6873.
63.
SzaloIM, GoffauxF, PirsonV, PiérardD, BallH, MainilJ. Presence in bovine enteropathogenic (EPEC) and enterohaemorrhagic (EHEC) Escherichia coli of genes encoding for putative adhesins of human EHEC strains. Res Microbiol, 2002; 153:653–658.
64.
TarrPI, BilgeSS, VaryJCJr, JelacicS, HabeebRL, WardTR, BaylorMR, BesserTE. Iha: A novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun, 2000; 68:1400–1407.
65.
TarrCL, LargeTM, MoellerCL, LacherDW, TarrPI, AchesonDW, WhittamTS. Molecular characterization of a serotype O121:H19 clone, a distinct Shiga toxin–producing clone of pathogenic Escherichia coli. Infect Immun, 2002; 70:6853–6859.
66.
TomaC, Martínez EspinosaE, SongT, MiliwebskyE, ChinenI, IyodaS, IwanagaM, RivasM. Distribution of putative adhesins in different seropathotypes of Shiga toxin–producing Escherichia coli. J Clin Microbiol, 2004; 42:4937–4946.
67.
TorresAG, GironJA, PernaNT, BurlandV, BlattnerFR, Avelino-FloresF, KaperJB. Identification and characterization of lpfABCC'DE, a fimbrial operon of enterohemorrhagic Escherichia coli O157:H7. Infect Immun, 2002; 70:5416–5427.
68.
TuX, NisanI, YonaC, HanskiE, RosenshineI. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol, 2003; 47:595–606.
69.
WellsJG, DavisBR, WachsmuthIK, RileyLW, RemisRS, SokolowR, MorrisGK. Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol, 1983; 18:512–520.
70.
WerberD, BeutinL, PichnerR, StarkK, FruthA. Shiga toxin–producing Escherichia coli serogroups in food and patients, Germany. Emerg Infect Dis, 2008; 14:1803–1806.
71.
ZhangW, BielaszewskaM, KucziusT, KarchH. Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx1c) in Escherichia coli strains isolated from humans. J Clin Microbiol, 2002; 40:1441–1446.
